HAS
35
-2
INTC
32
-4
EIX
62
-4
MDT
59
-3
FAST
60
-3
GPC
25
-2
AIG
36
-11
DGX
43
-3
UAL
82
-4
RL
68
-2
SYK
51
-9
CINF
31
-14
PH
64
5
TROW
37
-5
ZBH
56
-6
CAG
31
-2
AMGN
41
3
ZTS
29
-5
CSCO
53
-5
NSC
50
-4
HAS
35
-2
INTC
32
-4
EIX
62
-4
MDT
59
-3
FAST
60
-3
GPC
25
-2
AIG
36
-11
DGX
43
-3
UAL
82
-4
RL
68
-2
SYK
51
-9
CINF
31
-14
PH
64
5
TROW
37
-5
ZBH
56
-6
CAG
31
-2
AMGN
41
3
ZTS
29
-5
CSCO
53
-5
NSC
50
-4
Financhill
Back

Takeda Pharmaceutical Quote, Financials, Valuation and Earnings

AI DIVIDENDS: No. 1 Way to Collect Passive Income

Click here to get it for free.
Sell
31

TAK
Takeda Pharmaceutical

Last Price:
13.94
Seasonality Move:
4.98%

7 Day Trial

ALL ACCESS PASS

$ 7

#1 ETF for Monthly Dividend

Click HERE to learn more.

Takeda Pharmaceutical Price Quote

$13.94

Takeda Pharmaceutical Key Stats

Sell
31
Takeda Pharmaceutical (TAK) is a Sell
Day range:
$13.84 - $13.98
52-week range:
$12.58 - $15.08
Dividend yield:
4.39%
P/E ratio:
44.13
P/S ratio:
1.50
P/B ratio:
0.91%
Volume:
1.3M
Avg. volume:
1.8M
1-year change:
2.5%
Market cap:
$44.2B
Revenue:
$29.5B
EPS:
$0.31

How Much Does Takeda Pharmaceutical Make?

Is Takeda Pharmaceutical Growing As A Company?

  • What Is Takeda Pharmaceutical's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0%
  • What Is Takeda Pharmaceutical's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.08%

Takeda Pharmaceutical Stock Price Performance

What Is Takeda Pharmaceutical 52-Week High & Low?

Takeda Pharmaceutical Price To Free Cash Flow

Is It Risky To Buy Takeda Pharmaceutical?

Is Takeda Pharmaceutical Cash Flow Positive?

  • What Is TAK Cash Flow From Operations?
    Cash flow from operations (TTM) is $5.4B
  • What Is Takeda Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$5.5M
  • What Is Takeda Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.3B

Takeda Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    TAK return on invested capital is 1.21%
  • What Is Takeda Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is 0.97%
  • What Is TAK Return On Equity?
    ROE is a measure of profitability and is 2.03%

Takeda Pharmaceutical Earnings Date & Stock Price

Takeda Pharmaceutical Competitors

Takeda Pharmaceutical Dividend Yield

Takeda Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: -7.63% 0%
Revenue: 0.44% 6.36%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 16.07
Upside from Last Price: 15.25%

Major Shareholders

  • How many TAK shares are owned by institutional investors?
    196.4M TAK shares are owned by institutional investors
  • How many TAK shares are owned by insiders?
    0 TAK shares are owned by insiders